Our findings suggest that the measurement of C-terminal ALK or ROS1 protein could be a reliable diagnostic method for each fusion, whereas measuring C-terminal RET protein might be a diagnostic method with a potential to give false-positive results when detecting RET fusion in patients with lung cancer. The gene discussed is ALK; the disease is lung carcinoma.